Consistent with our observations in HER2/neu and Wnt1 transgenic mouse models, residual BT474-M1 lesions contained scattered GFP+ tumor cells that were quiescent, with only ~ 2% expressing Ki67 (Fig. 6c, e). This evidence concerns the gene ERBB2 and neoplasm.